Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-01

Clinical Trial Update: Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD) [NA]

View source ↗

Summary

This entry notes the completion of a clinical trial evaluating augmentation with prazosin for post-traumatic stress disorder and that results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Stress Disorders, Post-Traumatic, Combat Disorders | NA | Status: COMPLETED | Results posted: 2014-09-01